Pharmaceutical News

RSS

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

In a recent study published in the journal Science, researchers observed differential effector functions of antibodies elicited by Pfizer’s BNT162b2 and Moderna’s messenger ribonucleic acid (mRNA)-1273 coronavirus disease 2019 (COVID-19) vaccines.

4 Apr 2022

How well does the BNT162b2 vaccine protect children and teens against Omicron?

A study published in the New England Journal of Medicine investigated the vaccine efficiency of the Pfizer BioNTech (BNT162b2) vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant in children and adolescents.

4 Apr 2022

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Scientists discuss the pathogenic characteristics of SARS-CoV-2 and available therapeutic interventions for treating COVID-19.

3 Apr 2022

Johns Hopkins researchers explore the link between psychedelics and consciousness

Psychedelic drugs, like psilocybin, an ingredient found in so-called magic mushrooms, have shown promise in treating a range of addictions and mental health disorders.

31 Mar 2022

Despite doctors’ concerns, pharmacists get more leeway to offer treatment with testing

When Reyna or Justin Ansley or one of their three kids feels sick and needs to be tested for strep throat or flu, there's a good chance they'll head to their local pharmacy in Hemingford or Alliance, Nebraska. Dave Randolph, the proprietor of both locations of Dave's Pharmacy, can do a rapid test, give them medicine if they need it, and send them on their way.

31 Mar 2022

A ferritin nanoparticle candidate vaccine for COVID

In a recent study published on the bioRxiv* preprint server, the immunogenicity, and effectiveness of SARS-CoV-2 spike ferritin nanoparticle (SpFN) adjuvanted with aluminum hydroxide (AlOH3) or Army Liposomal Formulation QS-21 (ALFQ) in a cynomolgus macaque (CM) COVID-19 model was evaluated.

30 Mar 2022

Risk for anaphylaxis higher with two intravenous iron formulations

Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a study analyzing the medical records in a large database of older, Medicare patients.

29 Mar 2022

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

It was about 1 a.m. on April 19, 2016, when a burglary alarm sounded at Dale Hollow Pharmacy in Celina, a tiny town in the rolling, wooded hills near the Kentucky border.

29 Mar 2022

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Researchers determine whether there was any reduction in the death rate in elderly COVID-19 patients following the second booster dose.

28 Mar 2022

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Researchers analyze the effect of prior infection, vaccination, and hybrid immunity against SARS-CoV-2 BA.1 and BA.2 Omicron subvariant infections.

28 Mar 2022

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Researchers investigate the risk of death following vaccination as compared to SARS-CoV-2 infection.

28 Mar 2022

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Sen. Tim Scott, a rising star in the Republican Party with broad popularity in his home state of South Carolina, is getting showered with drug industry money before facing voters this fall.

28 Mar 2022

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

A new research paper published as an early release manuscript in the Nature Medicine journal compares the sensitivity of this strain as well as the earlier Delta and the newer BA.2 to therapeutic mAbs.

27 Mar 2022

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Researchers discuss the results of a clinical trial to assess the efficacy and safety of IV sarilumab for the treatment of hospitalized COVID-19 patients.

27 Mar 2022

Burt's Bees research demonstrates the efficacy of natural origin skincare regimens

Burt's Bees, a pioneer in nature-based skin care, announced its latest research findings on the efficacy of natural origin skincare regimens.

25 Mar 2022

NTU-developed coating for probiotics ensures effective delivery of beneficial bacteria into the intestine

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed probiotics with a unique edible coating that ensures the beneficial bacteria successfully reach the intestine once they are ingested.

25 Mar 2022

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns, a new study finds.

25 Mar 2022

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

A team of international scientists has developed an mRNA-based coronavirus disease 2019 (COVID-19) vaccine encoding the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant. The vaccine candidate has shown high efficacy in inducing neutralizing antibodies and protecting against delta infection in mice. The study is currently available on the bioRxiv* preprint server.

24 Mar 2022

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

Drugs known as antidopaminergic antiemetics (ADAs) that are widely used to relieve nausea and vomiting caused, for instance, by migraine, chemotherapy or radiotherapy, and after surgery are associated with an increased risk of ischaemic stroke, finds a study published by The BMJ today.

24 Mar 2022

Pharmaceutical News

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

How well does the BNT162b2 vaccine protect children and teens against Omicron?

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Johns Hopkins researchers explore the link between psychedelics and consciousness

Despite doctors’ concerns, pharmacists get more leeway to offer treatment with testing

A ferritin nanoparticle candidate vaccine for COVID

Risk for anaphylaxis higher with two intravenous iron formulations

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

Algal metabolites as novel drugs against viruses

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Burt's Bees research demonstrates the efficacy of natural origin skincare regimens

NTU-developed coating for probiotics ensures effective delivery of beneficial bacteria into the intestine

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News